EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Braxia Scientific's enterprise value is C$1.93 Mil.
Braxia Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$2.21 Mil. Therefore, Braxia Scientific's EV-to-Revenue for today is 0.87.
The historical rank and industry rank for Braxia Scientific's EV-to-Revenue or its related term are showing as below:
XCNQ:BRAX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.04 Med: 2.97 Max: 305.77
Current: 0.87
During the past 3 years, the highest EV-to-Revenue of Braxia Scientific was 305.77. The lowest was 0.04. And the median was 2.97.
XCNQ:BRAX's EV-to-Revenue is ranked better than 88.34% of 1038
companies
in the Biotechnology industry
Industry Median: 8.145
vs XCNQ:BRAX: 0.87
The historical data trend for Braxia Scientific's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Braxia Scientific's EV-to-Revenue
For the Biotechnology subindustry, Braxia Scientific's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braxia Scientific's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Braxia Scientific's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Braxia Scientific's EV-to-Revenue falls into.
Braxia Scientific's current Enterprise Value is C$1.93 Mil.
Braxia Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.21 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braxia Scientific's share price for today is C$0.005.
Braxia Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braxia Scientific EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Braxia Scientific's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Braxia Scientific (XCNQ:BRAX) Business Description
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:BRAX has been successfully added to your 